Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy

被引:3
作者
Choi, Min Joo [1 ,8 ]
Hyun, Hakjun [2 ]
Heo, Jung Yeon [2 ]
Bin Seo, Yu [3 ]
Noh, Ji Yun [4 ,5 ]
Cheong, Hee Jin [4 ,5 ]
Kim, Woo Joo [4 ,5 ]
Kim, Hwa Jung [6 ]
Choi, Ju-yeon [7 ]
Lee, Young Jae [7 ]
Chung, Eun Joo [7 ]
Kim, Su-Hwan [7 ]
Jeong, Hyeonji [7 ]
Kim, Byoungguk [7 ]
Song, Joon Young [4 ,5 ,8 ]
机构
[1] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Incheon, South Korea
[2] Ajou Univ, Sch Med, Dept Infect Dis, Suwon 441749, South Korea
[3] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis,Kangdong Sacred Heart Hosp, Seoul, South Korea
[4] Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea
[5] Korea Univ, Coll Med, Vaccine Innovat Ctr, Seoul, South Korea
[6] Ulsan Univ, Coll Med, Dept Clin Epidemiol & Biostat, Seoul, South Korea
[7] Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea
[8] Korea Univ, Guro Hosp, Dept Internal Med, Coll Med, 148 Gurodong Ro, Seoul 08308, South Korea
关键词
SARS-CoV-2; COVID-19; vaccines; Longevity; Immunogenicity; Booster shot; MEMORY;
D O I
10.1016/j.heliyon.2024.e27211
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Data on the durability of booster dose immunity of COVID-19 vaccines are relatively limited. Methods: Immunogenicity was evaluated for up to 9-12 months after the third dose of vaccination in 94 healthy adults. Results: Following the third dose, the anti-spike immunoglobulin G (IgG) antibody response against the wild-type was boosted markedly, which decreased gradually over time. However, even 9-12 months after the booster dose, both the median and geometric mean of anti-spike IgG antibody levels were higher than those measured 4 weeks after the second dose. Breakthrough infection during the Omicron-dominant period boosted neutralizing antibody titers against Omicron sublineages (BA.1 and BA.5) and the ancestral strain. T-cell immune response was efficiently induced and maintained during the study period. Conclusions: mRNA vaccine booster dose elicited durable humoral immunity for up to 1 year after the third dose and T-cell immunity was sustained during the study period, supporting an annual COVID-19 vaccination strategy.
引用
收藏
页数:9
相关论文
共 35 条
[1]   Covid-19 Breakthrough Infections in Vaccinated Health Care Workers [J].
Bergwerk, Moriah ;
Gonen, Tal ;
Lustig, Yaniv ;
Amit, Sharon ;
Lipsitch, Marc ;
Cohen, Carmit ;
Mandelboim, Michal ;
Gal Levin, Einav ;
Rubin, Carmit ;
Indenbaum, Victoria ;
Tal, Ilana ;
Zavitan, Malka ;
Zuckerman, Neta ;
Bar-Chaim, Adina ;
Kreiss, Yitshak ;
Regev-Yochay, Gili .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1474-1484
[2]   Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression [J].
Bobrovitz, Niklas ;
Ware, Harriet ;
Ma, Xiaomeng ;
Li, Zihan ;
Hosseini, Reza ;
Cao, Christian ;
Selemon, Anabel ;
Whelan, Mairead ;
Premji, Zahra ;
Issa, Hanane ;
Cheng, Brianna ;
Abu Raddad, Laith J. ;
Buckeridge, David L. ;
Van Kerkhove, Maria D. ;
Piechotta, Vanessa ;
Higdon, Melissa M. ;
Wilder-Smith, Annelies ;
Bergeri, Isabel ;
Feikin, Daniel R. ;
Arora, Rahul K. ;
Patel, Minal K. ;
Subissi, Lorenzo .
LANCET INFECTIOUS DISEASES, 2023, 23 (05) :556-567
[3]   Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity [J].
Choi, Min Joo ;
Heo, Jung Yeon ;
Seo, Yu Bin ;
Yoon, Young Kyung ;
Sohn, Jang Wook ;
Noh, Ji Yun ;
Cheong, Hee Jin ;
Kim, Woo Joo ;
Choi, Ju-yeon ;
Kim, Hwa Jung ;
Lee, Young Jae ;
Lee, Hye Won ;
Kim, Sung Soon ;
Kim, Byoungguk ;
Song, Joon Young .
FRONTIERS IN IMMUNOLOGY, 2023, 13
[4]  
FDA, FDA news release. Coronavirus (COVID-19) update: FDA authorizes Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose
[5]   Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].
Feng, Shuo ;
Phillips, Daniel J. ;
White, Thomas ;
Sayal, Homesh ;
Aley, Parvinder K. ;
Bibi, Sagida ;
Dold, Christina ;
Fuskova, Michelle ;
Gilbert, Sarah C. ;
Hirsch, Ian ;
Humphries, Holly E. ;
Jepson, Brett ;
Kelly, Elizabeth J. ;
Plested, Emma ;
Shoemaker, Kathryn ;
Thomas, Kelly M. ;
Vekemans, Johan ;
Villafana, Tonya L. ;
Lambe, Teresa ;
Pollard, Andrew J. ;
Voysey, Merryn .
NATURE MEDICINE, 2021, 27 (11) :2032-+
[6]   Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial [J].
Follmann, Dean ;
Janes, Holly E. ;
Buhule, Olive D. ;
Zhou, Honghong ;
Girard, Bethany ;
Marks, Kristen ;
Kotloff, Karen ;
Desjardins, Michael ;
Corey, Lawrence ;
Neuzil, Kathleen M. ;
Miller, Jacqueline M. ;
El Sahly, Hana M. ;
Baden, Lindsey R. .
ANNALS OF INTERNAL MEDICINE, 2022, 175 (09) :1258-+
[7]  
Food and Drug Administration, FDA briefing document: Future vaccination regimens addressing COVID-19
[8]   Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial [J].
Gilbert, Peter B. ;
Montefiori, David C. ;
McDermott, Adrian ;
Fong, Youyi ;
Benkeser, David ;
Deng, Weiping ;
Zhou, Honghong ;
Houchens, Christopher R. ;
Martins, Karen ;
Jayashankar, Lakshmi ;
Castellino, Flora ;
Flach, Britta ;
Lin, Bob C. ;
O'Connell, Sarah ;
McDanal, Charlene ;
Eaton, Amanda ;
Sarzotti-Kelsoe, Marcella ;
Lu, Yiwen ;
Yu, Chenchen ;
Borate, Bhavesh ;
van der Laan, Lars W. P. ;
Hejazi, Nima ;
Huynh, Chuong ;
Miller, Jacqueline ;
El Sahly, Hana M. ;
Baden, Lindsey R. ;
Baron, Mira ;
De la Cruz, Luis ;
Gay, Cynthia ;
Kalams, Spyros ;
Kelley, Colleen F. ;
Andrasik, Michele P. ;
Kublin, James G. ;
Corey, Lawrence ;
Neuzil, Kathleen M. ;
Carpp, Lindsay N. ;
Pajon, Rolando ;
Follmann, Dean ;
Donis, Ruben O. ;
Koup, Richard A. .
SCIENCE, 2022, 375 (6576) :43-+
[9]   Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection [J].
Gilboa, Mayan ;
Regev-Yochay, Gili ;
Mandelboim, Michal ;
Indenbaum, Victoria ;
Asraf, Keren ;
Fluss, Ronen ;
Amit, Sharon ;
Mendelson, Ella ;
Doolman, Ram ;
Afek, Arnon ;
Freedman, Laurence S. ;
Kreiss, Yitshak ;
Lustig, Yaniv .
JAMA NETWORK OPEN, 2022, 5 (09) :E2231778
[10]  
GISAID, hCoV-19 variants dashboard